Medplus Health Services Ltd Share Price

AGM Date: 26 Sep 2022

AGM 26/09/2022 We hereby draw your attention to the Annual Report of the company for the Financial Year 2021-22 along with the Notice of the 16th Annual General Meeting (Annual Report 2021-22) of the company, as published and circulated to the Shareholders on 3rd September 2022, wherein, subsequent to the Circulation of the same, certain inadvertent typographical errors were noticed in Page 45 'Management Discussion and Analysis', Page 54 'Annexure A to the Board Report' and Page 96 'Business Responsibility Report'. A Corrigendum to the Annual Report 2021-22 as attached in Annexure I, is being issued and emailed to all Shareholders of the company who received the same on 3rd September 2022. Further, we are enclosing herewith the Annual Report 2021-22 as Annexure II after incorporation of the annexed changes and the same is also available on the website of the Company. (As Per BSE Announcement Dated on 10.09.2022) Proceedings of the 16th AGM (As Per BSE Announcement dated on 27.09.2022) Pursuant to Regulation 44(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are enclosing the voting results of the 16th Annual General Meeting of the MedPlus Health Services Limited held on Monday, 26th September 2022 at 4.00 P.M. (IST) and concluded at 5:44 P.M. (IST) in the prescribed format together with scrutinizer's report. (As per BSE Announcement Dated on 28/9/2022)

AGM Date: 29 Sep 2023

Approval of 17th AGM Notice and fixed cut-off date to determine the e-voting. The Annual General Meeting of the Company will be held on Friday, September 29,2023. Publication of Notice after completion of dispatch of Annual Report along with Notice of Annual General Meeting of the Company (As Per BSE Announcement dated on 06.09.2023) Summary of the proceedings of the 17th Annual General Meeting of the Company under Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015 (As Per BSE Announcement Dated on 29.09.2023) Minutes of 17th Annual General Meeting of the Company held on September 29, 2023. (As Per BSE Announcement Dated on 10.10.2023) Transcript of 17th Annual General Meeting of the Company. (As Per BSE Announcement Dated on 20.10.2023)

AGM Date: 26 Sep 2024

Outcome of Board Meeting held on August 2, 2024 under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Summary of proceedings of 18th Annual General Meeting of the Company under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with clause 13 of Part A Para A of Schedule III to SEBI Listing Regulations (As Per Bse Announcement Dated on 26.09.2024) Submission of Voting Results along with Scrutinizer Report of the 18th Annual General Meeting of the Company (As Per BSE Announcement Dated on 27.09.2024) Transcript of 18th Annual General Meeting of the Company (As per BSE Announcement Dated on 08/10/2024)

EGM Date: 15 Dec 2023

COM 15/12/2023 Notice of the meeting of the Equity Shareholders and Unsecured Creditors of the Company pursuant to the Order of the National Company Law Tribunal, Hyderabad Bench- 1 (As Per BSE Announcement Dated on 10/11/2023) Copy of Newspaper Advertisement for notice of the meeting of the equity Shareholders and unsecured creditors of the Company pursuant to the order of the National Company Law Tribunal , Hyderabad Bench- 1 (As Per BSE Announcement dated on 11.11.2023) Outcome/ Summary proceedings of NCLT convened Meetings of Equity Shareholders and Trade Creditors of MedPlus Health Services Limited pursuant to NCLT order dated November 7, 2023 in connection with to consider and approve the Scheme of Amalgamation of MHS Pharmaceuticals Private Limited ('Transferor Company') with MedPlus Health Services Limited ('Transferee Company') and their respective shareholders and creditors (As per BSE Announcement Dated on 15/12/2023) Notice of the meeting of the Equity Shareholders and Unsecured Creditors of the Company pursuant to the Order of the National Company Law Tribunal, Hyderabad Bench- 1 (As Per BSE Announcement Dated on 17/12/2023)